36 vs 48 Wks Peg-Intron Plus Ribavirin for HCV Patients Without Rapid Virologic Response But Without HCV RNA at wk 8
NCT01683786
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis C Infection
Interventions
DRUG:
Pegintron + Riba
Sponsor
Chang Gung Memorial Hospital
Collaborators
[object Object]